Kodiak amends IPO

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) amended on Sept. 24 its proposed IPO on NASDAQ and now plans to sell 9 million shares at $13-$15. At the midpoint of its proposed range, the company would raise $126 million and be valued at $495 million. Morgan Stanley, BofA Merrill Lynch, Barclays and Chardan are underwriting the offering...